Eli Lilly and Company

Market Cap (Mar-08-2026)

934.235 Billion USD

World Rank (Jan-05-2024)

10

Market Cap (Jan-05-2024)

586.387 Billion USD

World Rank (Jul-30-2023)

16

Market Cap (Jul-30-2023)

435.220 Billion USD

World Rank (Jan-07-2022)

39

Market Cap (Jan-07-2022)

248.240 Billion USD

World Rank (Jan-01-2021)

69

Market Cap (Jan-01-2021)

161.510 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 13

Headquarters Country

USA

Nasdaq / NYSE Code

LLY

CEO

David A. Ricks

Chairman

Juan R. Luciano

Founders

Eli Lilly

Employee Count

39,000

Employee Count as of Date

As on 2022

Headquarters City/State

Indiana

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

65,179 Million USD

Annual Operating Income in USD

26,302 Million USD

Annual Net Income in USD

20,640 Million USD

Annual Results for Period Ending

Dec-2025 ending year

Total Assets in USD

112,476 Million USD

Total Liabilities in USD

85,941 Million USD

Total Equity in USD

26,535 Million USD

Balance Sheet for Period Ending

Dec-2025 ending year

Business Sector

Company Website

Eli Lilly And Company - Pharmaceutical Company

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

Eli Lilly is a healthcare and pharmaceutical company and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Headquarters is in USA.

As of Jan-05-2024, Eli Lilly market cap was 586 Billion USD and it is World Top 10th rank company by market cap.

As of August 2, 2026, Eli Lilly and Company had a market capitalization of approximately 1,029 billion USD, making it the world’s 14th-largest company by market capitalization.

Facts About Eli Lilly as of 2026:

Eli Lilly had 50,762 employees worldwide as of March 31, 2026.

Clinical research was conducted in more than 55 countries.

Research and development facilities were located in 8 countries.

Manufacturing plants were located in 10 countries.

Eli Lilly’s products were marketed in approximately 90 countries.

The company’s headquarters is located in Indianapolis, Indiana, USA.

Facts About Company

Eli Lilly Annual Revenue for the year ending December 2025 was 65,179 million USD, and Annual Net Income was 20,640 million USD.

Eli Lilly Annual Revenue for the year ending December 2024 was 45,043 million USD, and Annual Net Income was 10,590 million USD.

Eli Lilly Annual Revenue for the year ending December 2023 was 34,124 million USD, and Annual Net Income was 5,240 million USD.

As of December 31, 2025, Eli Lilly had approximately 50,000 employees worldwide.

As of December 31, 2024, Eli Lilly had approximately 47,000 employees worldwide.

As of December 31, 2023, Eli Lilly had approximately 43,000 employees worldwide.

Annual Results Summary

Eli Lilly and Company - Annual Revenue and Net Profit - in Million USD:

Fiscal Year	Fiscal Year End	Revenue ($mm)	Gross Profit ($mm)	Operating Profit ($mm)	Net Income ($mm)	Revenue YoY	Gross Margin	Operating Margin	Net Margin
2025	2025-12-31	65,179.0	54,127.0	26,302.0	20,640.0	44.7%	83.0%	40.4%	31.7%
2024	2024-12-31	45,042.7	36,624.4	12,899.0	10,590.0	32.0%	81.3%	28.6%	23.5%
2023	2023-12-31	34,124.1	27,041.9	6,457.9	5,240.4	19.6%	79.2%	18.9%	15.4%
2022	2022-12-31	28,541.4	21,911.6	7,127.3	6,244.8	0.8%	76.8%	25.0%	21.9%
2021	2021-12-31	28,318.4	21,005.6	6,357.1	5,581.7	15.4%	74.2%	22.4%	19.7%
2020	2020-12-31	24,539.8	19,056.5	6,058.0	6,193.7	10.0%	77.7%	24.7%	25.2%
2019	2019-12-31	22,319.0	17,598.0	4,974.0	8,318.0	(9.1%)	78.8%	22.3%	37.3%
2018	2018-12-31	24,555.7	18,125.7	3,720.9	3,232.0	7.4%	73.8%	15.2%	13.2%
2017	2017-12-31	22,871.3	16,720.5	1,896.9	(204.1)	7.8%	73.1%	8.3%	(0.9%)
2016	2016-12-31	21,222.1	15,512.0	3,261.2	2,737.6	-	73.1%	15.4%	12.9%

Balance Sheet Summary

Eli Lilly and Company - Balance Sheet Summary - in Million USD:

Fiscal Year	Total Assets (USD million)	Total Liabilities (USD million)	Total Equity (USD million)
2025	112,476	85,941	26,535
2024	78,715	64,443	14,272
2023	64,006	53,142	10,864
2022	49,490	38,715	10,775
2021	48,806	39,651	9,155
2020	46,633	40,808	5,825
2019	39,286	36,587	2,699
2018	43,908	32,999	10,909
2017	44,981	33,313	11,668
2016	38,806	24,725	14,081

Founded Year

1876

Institutional Investors

Top 30 Institutional Investors in ELI LILLY AND COMPANY as on SEP-30-2023

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	LILLY ENDOWMENT INC	09/30/2023	9,99,83,810	-10,45,000	-1.03%	$61,072,111
2	VANGUARD GROUP INC	09/30/2023	7,05,75,602	6,36,694	0.91%	$43,108,989
3	BLACKROCK INC.	09/30/2023	6,56,73,934	12,21,957	1.90%	$40,114,952
4	PNC FINANCIAL SERVICES GROUP, INC.	09/30/2023	5,17,89,291	-80,514	-0.16%	$31,633,935
5	STATE STREET CORP	09/30/2023	3,34,06,858	-4,71,559	-1.39%	$20,405,577
6	FMR LLC	09/30/2023	3,21,87,472	-6,89,613	-2.10%	$19,660,752
7	CAPITAL WORLD INVESTORS	09/30/2023	2,68,60,053	-7,528	-0.03%	$16,406,658
8	PRIMECAP MANAGEMENT CO/CA/	09/30/2023	2,30,63,536	-4,82,665	-2.05%	$14,087,669
9	PRICE T ROWE ASSOCIATES INC /MD/	09/30/2023	2,22,35,992	-19,24,967	-7.97%	$13,582,189
10	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	09/30/2023	1,71,57,660	-2,06,031	-1.19%	$10,480,242
11	JPMORGAN CHASE & CO	09/30/2023	1,58,03,192	16,63,578	11.77%	$9,652,906
12	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	1,57,14,225	5,08,724	3.35%	$9,598,563
13	WELLINGTON MANAGEMENT GROUP LLP	09/30/2023	1,28,54,465	-15,96,844	-11.05%	$7,851,764
14	MORGAN STANLEY	06/30/2023	1,24,68,075	3,05,630	2.51%	$7,615,750
15	NORTHERN TRUST CORP	09/30/2023	1,01,58,275	3,55,317	3.63%	$6,204,878
16	BANK OF AMERICA CORP /DE/	09/30/2023	98,37,955	-3,74,463	-3.67%	$6,009,220
17	NORGES BANK	12/31/2022	93,37,978	7,72,612	9.02%	$5,703,824
18	JENNISON ASSOCIATES LLC	09/30/2023	84,07,613	-1,73,825	-2.03%	$5,135,538
19	BANK OF NEW YORK MELLON CORP	09/30/2023	78,59,824	-5,79,799	-6.87%	$4,800,938
20	CAPITAL RESEARCH GLOBAL INVESTORS	09/30/2023	72,52,250	4,69,273	6.92%	$4,429,819
21	CAPITAL INTERNATIONAL INVESTORS	09/30/2023	61,39,754	-59,018	-0.95%	$3,750,285
22	LEGAL & GENERAL GROUP PLC	09/30/2023	59,24,805	-1,82,455	-2.99%	$3,618,989
23	NUVEEN ASSET MANAGEMENT, LLC	09/30/2023	52,74,778	1,74,753	3.43%	$3,221,940
24	ALLIANCEBERNSTEIN L.P.	09/30/2023	49,15,579	1,81,351	3.83%	$3,002,534
25	GOLDMAN SACHS GROUP INC	09/30/2023	48,39,056	-716	-0.02%	$2,955,792
26	FISHER ASSET MANAGEMENT, LLC	09/30/2023	44,57,074	2,18,773	5.16%	$2,722,470
27	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	44,35,311	88,016	2.03%	$2,709,177
28	AMUNDI	09/30/2023	44,01,713	-4,65,650	-9.57%	$2,688,654
29	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	43,72,782	-2,47,830	-5.36%	$2,670,983
30	AMERIPRISE FINANCIAL INC	09/30/2023	36,73,218	-4,32,630	-10.54%	$2,243,675